MedTrace Logo

Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis

NCT02436291 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-05-06

No results posted yet for this study

Summary

Open label study to evaluate the efficacy of CURE-EX device in the treatment of onychomycosis.

Conditions

  • Onychomycosis

Interventions

DEVICE

CURE-EX device

Treatment with CURE-EX device twice daily for 24-30 weeks.

Sponsors & Collaborators

  • MB Mazor Ltd.

    lead INDUSTRY

Principal Investigators

  • Avner Shemer, MD · Dermatology Clinic Natanya Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436291 on ClinicalTrials.gov